Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
GSP Neonatal IRT kit
The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome.
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Product information
Overview
The amount of the pancreatic enzyme, immunoreactive trypsin(ogen) (IRT) has been shown to be increased in blood of CF patients especially during the first weeks after birth.
GSP Neonatal IRT assay
The GSP Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.
- Linear calibration curve fitting - improved precision
- Incubation time 2 h
- Sensitive, robust DELFIA chemistry for confidence in results
- All reagents are ready to use
- The kit contains reagents and plates for 1152 tests (12 plates)
Specifications
| Application |
Newborn Screening
|
|---|---|
| Assay Technology |
DELFIA
|
| Brand |
GSP®
|
| Detection Method |
DELFIA
|
| Disorders |
Cystic Fibrosis
|
| Product Compatibility |
GSP
|
| Sample Type |
Dried blood spots
|
Resources
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
LanguageEnglishCountryAustralia
-
LanguageSpanishCountryBrazil
-
LanguageEnglishCountryCanada
-
LanguageChineseCountryChina
-
LanguageDanishCountryDenmark
-
LanguageEnglishCountryEU
-
LanguageFinnishCountryFinland
-
LanguageFrenchCountryFrance
-
LanguageGermanCountryGermany
-
LanguageItalianCountryItaly
Related products
of 1
How can we help you?
We are here to answer your questions.
